Literature DB >> 19800129

Spectroscopic study of the interaction of U(VI) with transferrin and albumin for speciation of U(VI) under blood serum conditions.

Gilles Montavon1, Christos Apostolidis, Frank Bruchertseifer, Urska Repinc, Alfred Morgenstern.   

Abstract

The quantitative description of the interactions of uranium with blood serum components is of high relevance for a rational design of molecules suitable for in vivo chelation of uranium. We have determined the stability constants for the complexation of U(VI) with human serum transferrin and albumin by time-resolved laser-induced fluorescence spectroscopy and difference ultraviolet spectroscopy. Both proteins interact strongly with U(VI), forming ternary complexes with carbonate acting as a synergistic anion. Together with literature data describing the interaction of U(VI) with low molecular weight inorganic and organic serum components, the speciation of U(VI) in blood serum was calculated. In agreement with published experimental data, the model calculation shows that complexation with proteins and carbonate ion governs U(VI) speciation; 35% of U(VI) is bound to proteins and 65% to carbonate. Among the protein pool, albumin is the main protein interacting with U(VI). In addition, the results show that Ca(II) must be considered in the model as a competitive metal ion with respect to U(VI) for binding to albumin surface sites. Based on these findings several promising molecules for in vivo chelation of (230)U could be identified.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19800129     DOI: 10.1016/j.jinorgbio.2009.08.010

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  13 in total

1.  Evidence of isotopic fractionation of natural uranium in cultured human cells.

Authors:  Eduardo Paredes; Emilie Avazeri; Véronique Malard; Claude Vidaud; Pascal E Reiller; Richard Ortega; Anthony Nonell; Hélène Isnard; Frédéric Chartier; Carole Bresson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-21       Impact factor: 11.205

2.  Chemical and biological insights into uranium-induced apoptosis of rat hepatic cell line.

Authors:  Fang Liu; Ke-Jie Du; Zhen Fang; Yong You; Ge-Bo Wen; Ying-Wu Lin
Journal:  Radiat Environ Biophys       Date:  2015-01-31       Impact factor: 1.925

3.  Interactions of uranyl ion with cytochrome b₅ and its His39Ser variant as revealed by molecular simulation in combination with experimental methods.

Authors:  Dun Wan; Li-Fu Liao; Min-Min Zhao; Min-Long Wu; Yi-Mou Wu; Ying-Wu Lin
Journal:  J Mol Model       Date:  2011-06-09       Impact factor: 1.810

4.  Stable Chelation of the Uranyl Ion by Acyclic Hexadentate Ligands: Potential Applications for 230U Targeted α-Therapy.

Authors:  Joshua J Woods; Ryan Unnerstall; Abbie Hasson; Diane S Abou; Valery Radchenko; Daniel L J Thorek; Justin J Wilson
Journal:  Inorg Chem       Date:  2022-02-09       Impact factor: 5.436

5.  Receptor recognition of transferrin bound to lanthanides and actinides: a discriminating step in cellular acquisition of f-block metals.

Authors:  Gauthier J-P Deblonde; Manuel Sturzbecher-Hoehne; Anne B Mason; Rebecca J Abergel
Journal:  Metallomics       Date:  2013-06       Impact factor: 4.526

6.  Sensitizing curium luminescence through an antenna protein to investigate biological actinide transport mechanisms.

Authors:  Manuel Sturzbecher-Hoehne; Christophe Goujon; Gauthier J-P Deblonde; Anne B Mason; Rebecca J Abergel
Journal:  J Am Chem Soc       Date:  2013-02-11       Impact factor: 15.419

7.  Can uranium follow the iron-acquisition pathway? Interaction of uranyl-loaded transferrin with receptor 1.

Authors:  Miryana Hémadi; Ngûyet-Thanh Ha-Duong; Sophie Plantevin; Claude Vidaud; Jean-Michel El Hage Chahine
Journal:  J Biol Inorg Chem       Date:  2009-12-30       Impact factor: 3.358

8.  Theoretical Study of Actinide(III)-DOTA Complexes.

Authors:  Attila Kovács
Journal:  ACS Omega       Date:  2021-05-11

9.  Modulating uranium binding affinity in engineered calmodulin EF-hand peptides: effect of phosphorylation.

Authors:  Romain Pardoux; Sandrine Sauge-Merle; David Lemaire; Pascale Delangle; Luc Guilloreau; Jean-Marc Adriano; Catherine Berthomieu
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

10.  Harnessing α-Emitting Radionuclides for Therapy: Radiolabeling Method Review.

Authors:  Hua Yang; Justin J Wilson; Chris Orvig; Yawen Li; D Scott Wilbur; Caterina F Ramogida; Valery Radchenko; Paul Schaffer
Journal:  J Nucl Med       Date:  2021-09-09       Impact factor: 11.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.